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Abstract
Background: The risk of nodal metastasis is higher in women with bigger breast. It is not clear if
this increase is due to the size of the breast (largely related to obesity) or is the result of larger
tumour size at presentation (due to delayed diagnosis). It is hypothesised that women with large
breasts are more likely to have node positive disease mainly attributable to their breast size.
Patients and methods: One hundred and twenty consecutive patients who underwent
mastectomy during the year 2004 and 2005 for primary breast cancers in a large Teaching Hospital
were included in the study. Patient's variable and tumour variable were collected and analysed by
SPSS® computer programme.
Results: It was found that big breasted women (those patients with mastectomy weight greater
than 800 g) had a significantly greater tumour size than those with smaller breasts (p = 0.019, Mann-
Whitney test) but there was no significant difference in grade (Kendall's tau-b = 0.055, p = 0.57) or
lymph node positivity (Kendall's tau-b = 0.011, p = 0.93) between the two groups. Although, the
tumour size was significantly greater in those with lymph node metastases (p < 0.001) but
mastectomy weight was not found to be significantly greater in those with lymph node metastases
(p = 0.11). For patients with similar tumour sizes mastectomy weight was not significantly greater
in those patients with lymph node metastases (p = 0.28).
Conclusion: It is concluded that increased incidence of lymph node positivity at presentation big-
breasted women is because of larger size of the primary tumour and not due to the size of the
breast alone.
Background
The present literature on the large size of breast and the
stage of breast cancer is controversial. The larger size of the
breasts is more common in obesity which is associated
with poor prognosis of breast cancer in both pre and post-
menopausal women[1]. It is argued that women with
large breasts have more advanced stage of disease at pres-
entation as the larger breasts of obese women may make
it difficult to detect early disease by palpation. It is also
suggested that women with large breasts may develop
lymph node metastasis at a smaller size of primary breast
cancer than those with smaller breast because of altered
host responses [2]. This poor outcome of breast cancer in
obesity can be attributed to either the larger tumour size
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at presentation or the increased susceptibility to lymph
node positivity. The evidence for either of these causes of
poor prognosis is complex and controversial. Most of
studies addressing these issues are case control or cohort
studies, the size of a large breast has not been defined by
most studies and the methodology for measuring big
breast is also varied using mammographic volume meas-
urements, self-reported bra cup size and the size of mas-
tectomy specimen [3-14]. Most but not all studies have
found an increasing tumour size with larger breasts but
only a few reported studies have found a high rate of node
positivity in larger breasts. It was hypothesised that
women with large breasts are more likely to have node
positive disease mainly attributable to their breast size.
Patients and methods
One hundred and twenty primary breast cancers operated
at a large Teaching Hospital were included in the study.
These were consecutive patients who underwent mastec-
tomy during the year 2004 and 2005. Patient's variable
and tumour variable were collected and analysed by SPSS
computer programme.
Statistical methods
Spearman correlation was used to measure association
between continuous variables, the Mann Whitney test for
the comparison of continuous variables between two
groups and Kendall's tau-b statistic to analyse ordinal var-
iables such as grade and lymph node positivity. Binary
logistic regression analysis was used to determine
whether, for patients with similar tumour sizes, mastec-
tomy specimen weight was a significant predictor of the
presence of lymph node metastases.
Results
A large breast was defined as a breast with mastectomy
specimen weight of 800 grams or more. It was found that
increasing weight of the mastectomy specimen was asso-
ciated with increasing risk of large tumour (rho = 0.26, p
= 0.008). The tumour size was significantly greater (p =
0.019, Mann-Whitney test) in those with mastectomy
weight greater than 800 g (Table 1). There was no signifi-
cant difference in grade (Kendall's tau-b = 0.055, p = 0.57)
or lymph node positivity (Kendall's tau-b = 0.011, p =
0.93) Table 1. The primary tumour size was significantly
greater in those patients with axillary lymph node metas-
tases (p < 0.001) but the mastectomy weight was not
found to be significantly greater in those with lymph node
metastases (p = 0.11). For patients with similar tumour
sizes mastectomy weight was not significantly greater in
those with lymph node metastases (p = 0.28) Table 1.
Obese women were more likely to have node positive dis-
ease but on Binary logistic regression it was found that
mastectomy weight itself was not a significant predictor of
lymph node positivity p = 0.69, while taking variable such
as tumour size, grade and ER status into account.
Discussion
This study demonstrates breast size bigger than 800 grams
is associated with increased risk of larger tumours and
large breast size alone is not associated with increased
incidence to lymph node metastasis. Therefore, the
advance disease at presentation of breast cancer is attrib-
utable to the size of the primary breast cancer. In the
present study the lymph node positivity rate in the large
and non-large breasts were similar suggesting the nodal
metastases is determined by the size of the primary
tumour and not by the size of the breast. There are other
factors that contribute to lymph node positivity. The most
significant of which include age of the patient, grade of
the tumour and oestrogen receptor status. The present
study found that there was no statistically significant dif-
ference between theses factors and lymph node positivity
in women with large breast and small breast.
Breast size and lymph node positivity
The present study did not find any evidence that the rate
of lymph node positivity was higher in women with larger
breast. The present study does not concord with an earlier
study, which reported that patients with big breasts had
more involved lymph nodes than women with small
Table 1: The relationship between mastectomy weight and lymph node positivity
Mastectomy 
weight < 800
Mastectomy weight equal to or
more than 800
P value and test
Tumour size in mm 21 (15–36.25) 27 (19.5–52.5) P = 0.019, Mann-Whitney test
Grade
I 7 (11%) 5 (10%) Kendall's tau-b = 0.055, p = 0.57
II 37 (58%) 25 (52%)
III 20 (31%) 18 (38%)
Lymph node
Negative 17 (27%) 9 (20%) Kendall's tau-b = 0.011, p = 0.93
1–3 14 (22%) 14 (31%)
>3 33 (52%) 22 (49%)International Seminars in Surgical Oncology 2008, 5:16 http://www.issoonline.com/content/5/1/16
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breasts, whether breast size was assessed by weight or
thickness [15]. We used mastectomy weight as a measure-
ment of breast size because this is the most definite, unbi-
ased and reproducible measure of the size of the breast.
This can also be regarded as a weakness of our study
because women who with very large breast who under-
went breast-conserving surgery might not be included in
this cohort. As women with highest quartile of the breast
weight may have undergone breast-conserving surgery,
this may have diluted the effect of size and the nodal
metastasis in the study population.
Mammographic breast volume and breast cancer size
In a study of 250 women breast volume calculated from
mammograms and compared with those of 250 age-
matched controls found that breast cancer patients had
larger breasts than age-matched healthy women [16].
Data for 2325 cases and 7008 controls from 4 centres
found that the larger cup size was associated with an
increased risk of breast cancer (P about 0.026), although
the association was found only among postmenopausal
women [6]. The influence of breast size (measured by vol-
ume from mammography) on the prognosis of 196
patients with early breast reported that breast size was sig-
nificantly associated independently with T stage (z = -
1.91, P = 0.05). Even though women with larger tumours
at presentation had larger breasts, breast size was not a sig-
nificant prognostic factor in early breast cancer [17].
Bra cup size and breast cancer size
A prospective study of 123 patients with primary breast
cancer to determine whether patients with larger breasts
(determined by cup size) have larger tumours reported
that patients with bigger breasts had larger tumours in
both symptomatic and screen detected group [18]. In a
large, population-based case-control study of women
aged 50 to 79 years in the USA Breast size before a preg-
nancy was found to be a positive predictor of postmeno-
pausal breast cancer, but this association was limited to
those who were especially lean as young women [19]. The
Nurses' Health Study II reported that a larger bra cup size
at a young age is associated with a higher incidence of pre-
menopausal breast cancer, though this association is lim-
ited to leaner women after studying the Bra cup size at age
20 among 89,268 premenopausal women aged 29–47
[20]. A case-case comparison found that Odds of late-
stage disease were increased with larger bra cup size (OR
for cup D vs. cup A = 1.61, 95% CI 1.04–2.48). These rela-
tionships were not modified by the method of detection.
Authors concluded that differences in etiologic effects,
rather than differences in detection methods, might
explain the relations observed between stage and both
BMI and breast size [21].
Conclusion
It is concluded that Increased lymph node positivity at
presentation of breast cancer in big-breasted women is
because of larger size of the primary tumour and not due
to the size of the breast alone.
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